← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Magnesio solfato eptaidrato currently has availability issues reported in 1 European register: Italy.
Shortage ATC — · also listed as: MAGNESIO SOLFATO EPTAIDRATO · data refreshed 11 November 2026
As of 11 November 2026, 1 of the 10 tracked registers list current availability issues for Magnesio solfato eptaidrato, covering 2 affected product presentations. Where agencies state a cause, manufacturing problems lead with 2 of the 2 stated-cause reports. The furthest expected-resolution date currently on file is 2027-01-25; the earliest is 2026-12-31. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇮🇹 Italy | Shortage MAGNESIO SOLFATO MONICO + 1 more productsMAGNESIO SOLFATO MONICO | 2026-11-09 | 2027-01-25 | Problemi produttivi Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
Every individual register entry for Magnesio solfato eptaidrato in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | MAGNESIO SOLFATO MONICO | Shortage | 2026-12-03 | 2027-01-25 | Problemi produttivi |
| 🇮🇹 IT | MAGNESIO SOLFATO MONICO | Shortage | 2026-11-09 | 2026-12-31 | Problemi produttivi |
Yes. As of 11 November 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-12-31 to 2027-01-25. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Magnesio solfato eptaidrato: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Magnesio solfato eptaidrato — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/magnesio-solfato-eptaidrato/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Magnesio solfato eptaidrato availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/magnesio-solfato-eptaidrato/">Magnesio solfato eptaidrato shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>